Concepedia

Vasileios Tsatlidis

VT

Statistics

Publications

5

Citations

285

H-Index

5

Active since

2016

Affiliations

Gateshead Health NHS Foundation Trust(Current)

Newcastle University

Tameside and Glossop Integrated Care NHS Foundation Trust

University of Sheffield

King's College Hospital NHS Foundation Trust

Vasileios Tsatlidis is an author at Gateshead Health NHS Foundation Trust specializing in medicine, serum thyroid-stimulating hormone measurement, and pharmacotherapy.

ORCID

Publications per year

2016–2023

5

Publications

5

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial

Solomon Tesfaye, Gordon Sloan, Jennifer Petrie et al. · The Lancet · 2022 · 191 citations · Full text

, , +17

Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease

Arjola Bano, Earn H Gan, Caroline Addison et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 36 citations · Full text

, , +12

The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds

Sviatlana Zhyzhneuskaya, Caroline Addison, Vasileios Tsatlidis et al. · Thyroid · 2016 · 23 citations

, , +14

The GLP‐1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes

Su Ann Tee, Vasileios Tsatlidis, Salman Razvi · Clinical Endocrinology · 2023 · 20 citations · Full text

, , +17

Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT

Solomon Tesfaye, Gordon Sloan, Jennifer Petrie et al. · Health Technology Assessment · 2022 · 15 citations · Full text

, , +17

1–5 of 5